Epicutantest-TROLAB[R]

Hauptinformation

  • Handelsname:
  • Epicutantest-TROLAB[R] D2485 Hydrocortison-17-butyrat 0,1%
  • Darreichungsform:
  • Salbe
  • Zusammensetzung:
  • Hydrocortison-17-butanoat 0.1% (m/V)
  • Verwenden für:
  • Menschen
  • Art der Medizin:
  • allopathic Droge

Dokumenten

  • für die Allgemeinheit:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie das Informationsblatt für die Öffentlichkeit.

  • Information für medizinisches Fachpersonal:
  • Das Informationsblatt für dieses Produkt ist derzeit nicht verfügbar, können Sie eine Anfrage an unseren Kundendienst zu senden und wir werden Sie benachrichtigen, sobald wir in der Lage, um es zu erhalten.


    Fordern Sie die Packungsbeilage für medizinisches Fachpersonal.

Lokalisierung

  • Erhältlich in:
  • Epicutantest-TROLAB[R] D2485 Hydrocortison-17-butyrat 0,1%
    Deutschland
  • Sprache:
  • Deutsch

Weitere Informationen

Status

  • Quelle:
  • BfArM - Bundesinstitut für Arzneimittel und Medizinprodukte
  • Zulassungsnummer:
  • PEI.D.03052.01.1
  • Letzte Änderung:
  • 12-02-2018

2-5-2018

April 17, 2018: Tampa Resident Sentenced to More Than 20 Years in Federal Prison for Tricare Health Care Fraud Scheme

April 17, 2018: Tampa Resident Sentenced to More Than 20 Years in Federal Prison for Tricare Health Care Fraud Scheme

April 17, 2018: Tampa Resident Sentenced to More Than 20 Years in Federal Prison for Tricare Health Care Fraud Scheme

FDA - U.S. Food and Drug Administration

17-5-2018

#ThrowBackThursday: May 17, 1971- The Public Health Service Bureau of Radiological Health transferred to FDA. It’s Mission: Protect against unnecessary human exposure to radiation from electronic products in the home and industry. #OnThisDay #FDAHistory

#ThrowBackThursday: May 17, 1971- The Public Health Service Bureau of Radiological Health transferred to FDA. It’s Mission: Protect against unnecessary human exposure to radiation from electronic products in the home and industry. #OnThisDay #FDAHistory

#ThrowBackThursday: May 17, 1971- The Public Health Service Bureau of Radiological Health transferred to FDA. It’s Mission: Protect against unnecessary human exposure to radiation from electronic products in the home and industry. #OnThisDay #FDAHistory

FDA - U.S. Food and Drug Administration

18-4-2018

Health Tip: Understanding Allergy Blood Testing

Health Tip: Understanding Allergy Blood Testing

Title: Health Tip: Understanding Allergy Blood TestingCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Health Tip: If You're Pregnant and Have Diabetes

Health Tip: If You're Pregnant and Have Diabetes

Title: Health Tip: If You're Pregnant and Have DiabetesCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Organs From Opioid OD Victims Are Saving Lives: Study

Organs From Opioid OD Victims Are Saving Lives: Study

Title: Organs From Opioid OD Victims Are Saving Lives: StudyCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Go Nuts for Heart Health

Go Nuts for Heart Health

Title: Go Nuts for Heart HealthCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Can Mom-to Be's' Weight Affect Daughters' Risk for Early Puberty?

Can Mom-to Be's' Weight Affect Daughters' Risk for Early Puberty?

Title: Can Mom-to Be's' Weight Affect Daughters' Risk for Early Puberty?Category: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

'Flexitarian' Eating: Part Vegetarian, Part Not

'Flexitarian' Eating: Part Vegetarian, Part Not

Title: 'Flexitarian' Eating: Part Vegetarian, Part NotCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

18-4-2018

Sen. John McCain Recovering After Intestinal Surgery

Sen. John McCain Recovering After Intestinal Surgery

Title: Sen. John McCain Recovering After Intestinal SurgeryCategory: Health NewsCreated: 4/17/2018 12:00:00 AMLast Editorial Review: 4/17/2018 12:00:00 AM

US - MedicineNet

17-4-2018

Autologous skeletal myoblasts expanded ex vivo (Assistance Publique - Hopitaux de Paris (APHP))

Autologous skeletal myoblasts expanded ex vivo (Assistance Publique - Hopitaux de Paris (APHP))

Autologous skeletal myoblasts expanded ex vivo (Active substance: Autologous skeletal myoblasts expanded ex vivo) - Refusal of orphan designation - Commission Decision (2018)2354 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/144/17

Europe -DG Health and Food Safety

1-4-2018

01.04.2018: Metoject 17.5 mg, Injektionslösung, Spritze(n), 39.35, -13.2%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer57272090 ZulassungsinhaberGebro Pharma AGNameMetoject 17.5 mg, InjektionslösungRegistrierungsdatum02.09.2005Original/GenerikumOriginalErstzulassung Sequenz17.11.2011ATC-KlassierungMethotrexate (L04AX03)Revisionsdatum WHOWHO-DDDGültig bis01.09.2020Index Therapeuticus (BSV)07.10.60.PackungsgrösseSpritze(n)Index Therapeuticus (Swissmedic)07.10.60.Beschreibung AbgabekategorieA  SL EintragJaAnwendungArthritis und PsoriasisFachinformationFIP...

ODDB -Open Drug Database

28-3-2018

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (FGK Representative Service GmbH)

EU/3/17/1876 (Active substance: Sodium (1R,3R,4R,5S)-3-({2-N-acetylamino-2-deoxy-3-O-[(1S)-1-carboxylato-2-cyclohexylethyl]-beta-D-galactopyranosyl}oxy)-4-({6-deoxy-alpha-L-galactopyranosyl}oxy)-5-ethyl-cyclohexan-1-yl-(38-oxo-2,5,8,11,14,17,20,23,26,29,32,35-dodecaoxa-39-azahentetracontan-41-yl)carboxamide) - Transfer of orphan designation - Commission Decision (2018)2011 of Wed, 28 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/010/17/T/01

Europe -DG Health and Food Safety

21-3-2018

EU/3/17/1861 (Roivant Sciences Ireland Limited)

EU/3/17/1861 (Roivant Sciences Ireland Limited)

EU/3/17/1861 (Active substance: (S)-8-{2-amino-6-[1-(5-chloro-biphenyl-2-yl)-(R)-2,2,2-trifluoro-ethoxy]-pyrimidin-4-yl}-2,8-diaza-spiro[4.5]decane-3-carboxylic acid ethyl ester) - Transfer of orphan designation - Commission Decision (2018)1826 of Wed, 21 Mar 2018 European Medicines Agency (EMA) procedure number: EMA/OD/299/16/T/01

Europe -DG Health and Food Safety

1-3-2018

01.03.2018: Candesartan Takeda 8 mg, Tabletten, 28 Tablette(n), 17.90, -9.4%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer62569004 CMZulassungsinhaberTakeda Pharma AGNameCandesartan Takeda 8 mg, TablettenRegistrierungsdatum12.03.2012Original/GenerikumOriginalErstzulassung Sequenz12.03.2012ATC-KlassierungCandesartan (C09CA06)Revisionsdatum WHOWHO-DDDGültig bis11.03.2022Index Therapeuticus (BSV)02.07.10.Packungsgrösse28 Tablette(n)Index Therapeuticus (Swissmedic)02.07.10.Beschreibung AbgabekategorieB  SL EintragJaAnwendungEssentielle Hypertonie und Herzinsu...

ODDB -Open Drug Database

12-2-2018

Rheumatoid Arthritis (RA): 17 Warning Signs of Serious Complications

Rheumatoid Arthritis (RA): 17 Warning Signs of Serious Complications

Title: Rheumatoid Arthritis (RA): 17 Warning Signs of Serious ComplicationsCategory: Doctor's & Expert's views on SymptomsCreated: 7/7/2001 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM

US - MedicineNet

1-2-2018

01.02.2018: Actemra 80 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung, Durchstechflasche(n), 209.25, -10.9%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer58868001 ZulassungsinhaberRoche Pharma (Schweiz) AGNameActemra 80 mg/4 ml, Konzentrat zur Herstellung einer InfusionslösungRegistrierungsdatum02.12.2008  Erstzulassung Sequenz02.12.2008ATC-KlassierungTocilizumab (L04AC07)Revisionsdatum WHOWHO-DDDGültig bis01.12.2018Index Therapeuticus (BSV)07.15.PackungsgrösseDurchstechflasche(n)Index Therapeuticus (Swissmedic)07.15.Beschreibung AbgabekategorieA  SL EintragJaAnwendungRheumato...

ODDB -Open Drug Database

1-2-2018

01.02.2018: Actemra 200 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung, Durchstechflasche(n), 498.45, -11.4%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer58868002 ZulassungsinhaberRoche Pharma (Schweiz) AGNameActemra 200 mg/10 ml, Konzentrat zur Herstellung einer InfusionslösungRegistrierungsdatum02.12.2008  Erstzulassung Sequenz02.12.2008ATC-KlassierungTocilizumab (L04AC07)Revisionsdatum WHOWHO-DDDGültig bis01.12.2018Index Therapeuticus (BSV)07.15.PackungsgrösseDurchstechflasche(n)Index Therapeuticus (Swissmedic)07.15.Beschreibung AbgabekategorieA  SL EintragJaAnwendungRheuma...

ODDB -Open Drug Database

1-2-2018

01.02.2018: Actemra 400 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung, Durchstechflasche(n), 980.55, -11.3%

ODDB.org: Open Drug DatabaseSwissmedic-Nummer58868003 ZulassungsinhaberRoche Pharma (Schweiz) AGNameActemra 400 mg/20 ml, Konzentrat zur Herstellung einer InfusionslösungRegistrierungsdatum02.12.2008  Erstzulassung Sequenz02.12.2008ATC-KlassierungTocilizumab (L04AC07)Revisionsdatum WHOWHO-DDDGültig bis01.12.2018Index Therapeuticus (BSV)07.15.PackungsgrösseDurchstechflasche(n)Index Therapeuticus (Swissmedic)07.15.Beschreibung AbgabekategorieA  SL EintragJaAnwendungRheuma...

ODDB -Open Drug Database

24-1-2018

EU/3/17/1971 (Edison Orphan Pharma BV)

EU/3/17/1971 (Edison Orphan Pharma BV)

EU/3/17/1971 (Active substance: Vatiquinone) - Orphan designation - Commission Decision (2018)393 of Wed, 24 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/145/17

Europe -DG Health and Food Safety

20-1-2018

EU/3/17/1965 (Duchenne UK)

EU/3/17/1965 (Duchenne UK)

EU/3/17/1965 (Active substance: Metformin and L-citrulline) - Orphan designation - Commission Decision (2018)387 of Sat, 20 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/154/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1958 (Voisin Consulting S.A.R.L.)

EU/3/17/1958 (Voisin Consulting S.A.R.L.)

EU/3/17/1958 (Active substance: Allogeneic umbilical cord blood CD34+ cells cultured ex vivo with Notch ligand Delta1) - Orphan designation - Commission Decision (2018)379 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/192/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1970 (Rare Partners srl Impresa Sociale)

EU/3/17/1970 (Rare Partners srl Impresa Sociale)

EU/3/17/1970 (Active substance: Sirolimus) - Orphan designation - Commission Decision (2018)392 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/184/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1967 (Millendo Therapeutics Ltd)

EU/3/17/1967 (Millendo Therapeutics Ltd)

EU/3/17/1967 (Active substance: N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt) - Orphan designation - Commission Decision (2018)389 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/179/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1957 (uniQure Biopharma B.V.)

EU/3/17/1957 (uniQure Biopharma B.V.)

EU/3/17/1957 (Active substance: Adeno-associated viral vector serotype 5 encoding a microRNA targeted to human huntingtin gene) - Orphan designation - Commission Decision (2018)378 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/151/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1956 (Quintiles Ireland Limited)

EU/3/17/1956 (Quintiles Ireland Limited)

EU/3/17/1956 (Active substance: Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human iduronate 2-sulfatase gene) - Orphan designation - Commission Decision (2018)377 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/168/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1955 (Quintiles Ireland Limited)

EU/3/17/1955 (Quintiles Ireland Limited)

EU/3/17/1955 (Active substance: Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human alpha L-iduronidase gene) - Orphan designation - Commission Decision (2018)376 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/167/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1966 (Sirius Regulatory Consulting Limited)

EU/3/17/1966 (Sirius Regulatory Consulting Limited)

EU/3/17/1966 (Active substance: N-(bromoacetyl)-3,3-dinitroazetidine) - Orphan designation - Commission Decision (2018)388 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/166/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1964 (Incyte Biosciences UK Ltd)

EU/3/17/1964 (Incyte Biosciences UK Ltd)

EU/3/17/1964 (Active substance: Itacitinib) - Orphan designation - Commission Decision (2018)385 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/169/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1963 (Professor Pascale De Lonlay)

EU/3/17/1963 (Professor Pascale De Lonlay)

EU/3/17/1963 (Active substance: Hydroxychloroquine sulphate) - Orphan designation - Commission Decision (2018)384 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/177/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1962 (MWB Consulting Ltd)

EU/3/17/1962 (MWB Consulting Ltd)

EU/3/17/1962 (Active substance: Humanised Fc-engineered monoclonal antibody against CD19) - Orphan designation - Commission Decision (2018)383 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/155/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1961 (Astellas Pharma Europe B.V.)

EU/3/17/1961 (Astellas Pharma Europe B.V.)

EU/3/17/1961 (Active substance: Gilteritinib) - Orphan designation - Commission Decision (2018)382 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/175/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1960 (Atlas Molecular Pharma S.L.)

EU/3/17/1960 (Atlas Molecular Pharma S.L.)

EU/3/17/1960 (Active substance: Ciclopirox) - Orphan designation - Commission Decision (2018)381 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/186/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1959 (GW Research Ltd)

EU/3/17/1959 (GW Research Ltd)

EU/3/17/1959 (Active substance: Cannabidiol) - Orphan designation - Commission Decision (2018)380 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/165/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1969 (University of Cambridge)

EU/3/17/1969 (University of Cambridge)

EU/3/17/1969 (Active substance: Recombinant adeno-associated viral vector serotype 2/1 encoding human beta-hexosaminidase alpha and beta subunits) - Orphan designation - Commission Decision (2018)391 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/182/17

Europe -DG Health and Food Safety

19-1-2018

EU/3/17/1968 (Regintel Limited)

EU/3/17/1968 (Regintel Limited)

EU/3/17/1968 (Active substance: Pyrazolo[1,5-a]pyrimidine, 3-[4-chloro-2-(4-morpholinyl)-5-thiazolyl]-7-(1-ethylpropyl)-2,5-dimethyl-pyrazolo[1,3-a]pyrimidine) - Orphan designation - Commission Decision (2018)390 of Fri, 19 Jan 2018 European Medicines Agency (EMA) procedure number: EMA/OD/164/17

Europe -DG Health and Food Safety

18-1-2018

Health Tip: Is Your Food Still Good After Power Outage?

Health Tip: Is Your Food Still Good After Power Outage?

Title: Health Tip: Is Your Food Still Good After Power Outage?Category: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Health Tip: If You're Stuck Inside During a Winter Storm

Health Tip: If You're Stuck Inside During a Winter Storm

Title: Health Tip: If You're Stuck Inside During a Winter StormCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Creativity May Rely on 'Teamwork' in the Brain

Creativity May Rely on 'Teamwork' in the Brain

Title: Creativity May Rely on 'Teamwork' in the BrainCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Sleep Better, Lose Weight?

Sleep Better, Lose Weight?

Title: Sleep Better, Lose Weight?Category: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Don't Rely on Just One Blood Pressure Test for Kids: Study

Don't Rely on Just One Blood Pressure Test for Kids: Study

Title: Don't Rely on Just One Blood Pressure Test for Kids: StudyCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

The Second Stage of Diet Resolutions

The Second Stage of Diet Resolutions

Title: The Second Stage of Diet ResolutionsCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

18-1-2018

Salmonella Outbreak Linked to Coconut Tree Brand Frozen Shredded Coconut

Salmonella Outbreak Linked to Coconut Tree Brand Frozen Shredded Coconut

Title: Salmonella Outbreak Linked to Coconut Tree Brand Frozen Shredded CoconutCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/17/2018 12:00:00 AM

US - MedicineNet

15-12-2017

EU/3/17/1950 (MeiraGTx UK II Limited)

EU/3/17/1950 (MeiraGTx UK II Limited)

EU/3/17/1950 (Active substance: Adenovirus associated viral vector serotype 8 containing the human AIPL1 gene) - Orphan designation - Commission Decision (2017)8782 of Fri, 15 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/162/17

Europe -DG Health and Food Safety

15-12-2017

EU/3/17/1954 (AbbVie Ltd)

EU/3/17/1954 (AbbVie Ltd)

EU/3/17/1954 (Active substance: Venetoclax) - Orphan designation - Commission Decision (2017)8786 of Fri, 15 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/131/17

Europe -DG Health and Food Safety

15-12-2017

EU/3/17/1951 (Clinical Network Services (UK) Ltd)

EU/3/17/1951 (Clinical Network Services (UK) Ltd)

EU/3/17/1951 (Active substance: Agammaglobulinaemia tyrosine kinase) - Orphan designation - Commission Decision (2017)8783 of Fri, 15 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/157/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1952 (PhaseRx Ireland, Ltd)

EU/3/17/1952 (PhaseRx Ireland, Ltd)

EU/3/17/1952 (Active substance: Modified messenger ribonucleic acid encoding human argininosuccinate lyase enzyme encapsulated into lipid nanoparticles) - Orphan designation - Commission Decision (2017)8784 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/153/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1953 (Protalix B.V)

EU/3/17/1953 (Protalix B.V)

EU/3/17/1953 (Active substance: Pegunigalsidase alfa) - Orphan designation - Commission Decision (2017)8785 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/138/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1949 (IntraBio Ltd)

EU/3/17/1949 (IntraBio Ltd)

EU/3/17/1949 (Active substance: Acetylleucine) - Orphan designation - Commission Decision (2017)8781 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/158/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1948 (Premier Research Group Limited)

EU/3/17/1948 (Premier Research Group Limited)

EU/3/17/1948 (Active substance: 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl) - Orphan designation - Commission Decision (2017)8780 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/135/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1947 (NeuroVive Pharmaceutical AB)

EU/3/17/1947 (NeuroVive Pharmaceutical AB)

EU/3/17/1947 (Active substance: 2-isopropyl-3H-naphtho[1,2-d]imidazole-4,5-dione) - Orphan designation - Commission Decision (2017)8779 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/132/17

Europe -DG Health and Food Safety

14-12-2017

EU/3/17/1946 (FGK Representative Service GmbH)

EU/3/17/1946 (FGK Representative Service GmbH)

EU/3/17/1946 (Active substance: (2S,4R)-1-(2-(3-acetyl-5-(2-methylpyrimidine-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridine-2-yl)-4-fluoropyrrolidine-2-carboxamide) - Orphan designation - Commission Decision (2017)8778 of Thu, 14 Dec 2017 European Medicines Agency (EMA) procedure number: EMA/OD/156/17

Europe -DG Health and Food Safety

17-11-2017

Lemtrada (Genzyme Therapeutics Ltd)

Lemtrada (Genzyme Therapeutics Ltd)

Lemtrada (Active substance: Alemtuzumab) - Centralised - 2-Monthly update - Commission Decision (2017) 7765 of Fri, 17 Nov 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/3718/II/17

Europe -DG Health and Food Safety

17-11-2017

Dr. Tommy John Hopes Fewer Young Athletes Need Dad's Namesake Surgery

Dr. Tommy John Hopes Fewer Young Athletes Need Dad's Namesake Surgery

Title: Dr. Tommy John Hopes Fewer Young Athletes Need Dad's Namesake SurgeryCategory: Health NewsCreated: 11/17/2017 12:00:00 AMLast Editorial Review: 11/17/2017 12:00:00 AM

US - MedicineNet

17-11-2017

5 Tasty Diet Desserts

5 Tasty Diet Desserts

Title: 5 Tasty Diet DessertsCategory: Health NewsCreated: 11/17/2017 12:00:00 AMLast Editorial Review: 11/17/2017 12:00:00 AM

US - MedicineNet

14-11-2017

EU/3/17/1835 (Abeona Therapeutics Europe SL)

EU/3/17/1835 (Abeona Therapeutics Europe SL)

EU/3/17/1835 (Active substance: Ex-vivo-expanded autologous keratinocytes transduced with retroviral vector containing the COL7A1 gene) - Transfer of orphan designation - Commission Decision (2017)7626 of Tue, 14 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/283/16/T/01

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1933 (Quintiles Ireland Limited)

EU/3/17/1933 (Quintiles Ireland Limited)

EU/3/17/1933 (Active substance: (1'R,6'R)-3-(benzylamine)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione) - Orphan designation - Commission Decision (2017)7555 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/142/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1935 (Edvince AB)

EU/3/17/1935 (Edvince AB)

EU/3/17/1935 (Active substance: 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) - Orphan designation - Commission Decision (2017)7557 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/120/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1945 (Medical Need Europe AB)

EU/3/17/1945 (Medical Need Europe AB)

EU/3/17/1945 (Active substance: Tiratricol) - Orphan designation - Commission Decision (2017)7567 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/128/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1944 (Duchenne UK)

EU/3/17/1944 (Duchenne UK)

EU/3/17/1944 (Active substance: Tamoxifen citrate) - Orphan designation - Commission Decision (2017)7566 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/133/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1943 (REGENXBIO EU Limited)

EU/3/17/1943 (REGENXBIO EU Limited)

EU/3/17/1943 (Active substance: Recombinant adeno-associated viral vector serotype 9 containing human iduronate-2-sulfatase gene) - Orphan designation - Commission Decision (2017)7565 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/134/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1942 (Celleron Therapeutics Limited)

EU/3/17/1942 (Celleron Therapeutics Limited)

EU/3/17/1942 (Active substance: N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin)benzamide) - Orphan designation - Commission Decision (2017)7564 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/121/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1940 (Novo Nordisk A/S)

EU/3/17/1940 (Novo Nordisk A/S)

EU/3/17/1940 (Active substance: Concizumab) - Orphan designation - Commission Decision (2017)7563 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/116/17

Europe -DG Health and Food Safety

10-11-2017

EU/3/17/1939 (CSL Behring GmbH)

EU/3/17/1939 (CSL Behring GmbH)

EU/3/17/1939 (Active substance: C1-esterase-inhibitor human) - Orphan designation - Commission Decision (2017)7561 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/105/17

Europe -DG Health and Food Safety